Milou Amber Hogervorst (Milou A Hogervorst, Milou Hogervorst)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 7

Top Topics

Transcription Factor

Clinical Evaluation

Health Promotion

Top Venues

International journal of technology assessment in health care

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Milou Amber Hogervorst, Rick A Vreman, Inkatuuli Heikkinen, Indranil Bagchi, Iñaki Gutierrez-Ibarluzea, Bettina Ryll, Hans-Georg Eichler, Elena Petelos, Sean Tunis, Claudine Sapede, Wim G Goettsch, Rosanne Janssens, Isabelle Huys, Liese Barbier, Deirdre DeJean, Valentina Strammiello, Dimitra Lingri, Melinda Goodall, Magdalini Papadaki, Massoud Toussi, Despina Voulgaraki, Ania Mitan, Wija Oortwijn
UNCERTAINTY MANAGEMENT IN REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING ON DRUGS: GUIDANCE OF THE HTAi-DIA WORKING GROUP. International journal of technology assessment in health care (2023)
Milou Amber Hogervorst, Rick A Vreman, Inkatuuli Heikkinen, Wija Oortwijn
Response to uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group - author's reply. International journal of technology assessment in health care 40 (1) (2023)
Milou Amber Hogervorst, Rick A Vreman, Anna Zawada, Magdalena Zielińska, Dalia M Dawoud, Brigit A de Jong, Aukje K Mantel-Teeuwisse, Wim G Goettsch
Synergy between health technology assessments and clinical guidelines for multiple sclerosis. Clinical and translational science (2023)
Milou Amber Hogervorst, Rick A Vreman, Inkatuuli Heikkinen, Wija Oortwijn
RESPONSE TO UNCERTAINTY MANAGEMENT IN REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING ON DRUGS: GUIDANCE OF THE HTAi-DIA WORKING GROUP - AUTHOR'S REPLY. International journal of technology assessment in health care (2023)
Milou Amber Hogervorst, Rick A Vreman, Inkatuuli Heikkinen, Wija Oortwijn
Response to uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group - author's reply. International journal of technology assessment in health care 40 (1) (2023)
Milou Amber Hogervorst, Rick A Vreman, Inkatuuli Heikkinen, Wija Oortwijn
Response to uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group - author's reply. International journal of technology assessment in health care 40 (1) (2023)
Milou Amber Hogervorst, Mathias Møllebæk, Rick A Vreman, Ting-An Lu, Junfeng Wang, Marie Louise De Bruin, Hubert G M Leufkens, Aukje K Mantel-Teeuwisse, Wim Goettsch
Perspectives on how to build bridges between regulation, health technology assessment and clinical guideline development: a qualitative focus group study with European experts. BMJ open 13 (8) (2023)